论文部分内容阅读
普鲁卡因静脉点滴系封闭疗法之一,临床上较常应用,由其引起副作用者屡有报导,仅据笔者手头的资料尚未见到有引起血红蛋白尿者。笔者在临床实践中先后遇到两例,既往对普鲁卡因无过敏史,皮肤试验亦阴性,静脉点滴普鲁卡因后出现血红蛋白尿。例1:男,21岁,患银屑病。入院体检除发育及营养欠佳外均正常。化验:血常规正常;尿蛋白微量,并有极少白细胞。住院后肌注维生素 B_(12),内服三溴合剂,外用5%白降汞软膏,经77天未见好转。随以0.25%普鲁卡因液静脉滴注250毫升,第一天经过尚好,唯
Procaine intravenous line closure therapy, one of the more clinically used, the side effects caused by its repeated reports, only according to the author’s information has not yet been found to cause hemoglobinuria. I met in clinical practice in two cases, past no history of allergy to procaine, skin test was negative, intravenous drip of procaine hemoglobinuria. Example 1: Male, 21 years old, suffering from psoriasis. Admission except physical development and poor nutrition are normal. Laboratory tests: normal blood; urinary protein trace, and few white blood cells. After in hospital intramuscular injection of vitamin B_ (12), oral bromine 3 bromides, topical white drop mercury ointment, no improvement after 77 days. With 0.25% procaine intravenous infusion of 250 ml, the first day after good, only